Global /Japan /Healthcare /Medical Devices /7575
chevron_leftBack
Japan Lifeline Co., Ltd. logo

Japan Lifeline Co., Ltd.

7575
TSE: 7575 Delayed
1,404JPY -0.4%
8.76 USD
As of 13 June 2026, Japan Lifeline Co., Ltd. has a market cap of $615.31M USD, ranking #13797 globally and #1006 in Japan. It ranks #1239 in the Healthcare sector, and #249 in the Medical Devices industry.
Global Rank
13797
Country Rank
1006
Sector Rank
1239
Industry Rank
249
Key Stats
Market Cap
$615.31MUSD
98.5B JPY
Enterprise Value
$580.48MUSD
93.08B JPY
Revenue (TTM)
$363.59MUSD
58.2B JPY
EBITDA (TTM)
$87.08MUSD
13.96B JPY
Net Income (TTM)
$56.64MUSD
9.07B JPY
EBITDA Margin
24%
Profit Margin
16%
PE Ratio
10.9
Forward PE
10.7
PS Ratio
1.7
PB Ratio
1.6
EV/EBITDA
6.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Keisuke Suzuki open_in_new
Employees
1,250
Founded
1981
Website
japanlifeline.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.4% 1.7% -1.7% -9.7% -3.4% -8.5%

News

Loading...

Markets

Exchange Ticker Price
Tokyo Stock Exchange
MIC: XTKS
PRIMARY
7575
日本ライフライン株式会社
ISIN: JP3754500001
Shares Out.:
70.154M1 Shares Float: 47.589M2
TV:
SA:
YF:
GF:
BA:
MS:
1,404 JPY
Frankfurt Stock Exchange
MIC: XFRA
L8B
日本ライフライン株式会社
ISIN: JP3754500001
TV:
SA:
YF:
GF:
BA:
L8B
MS:
7.40 EUR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Japan Lifeline Co., Ltd.

Japan Lifeline Co., Ltd., a medical device company, engages in manufacturing and sale of medical device in Japan. The company’s cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, disposable ECG recorder, and venous vascular closure system. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts, as well as embolic coil deploying systems. In addition, the company offers gastrointestinal intervention products, including cholangioscope, biliary tube stent, papillary balloon dilatation catheter, self-expandable duodenal and colonic stent, endoscopic guidewire, and radiofrequency ablation systems; structural heart disease intervention products, such as radiofrequency wires and atrial septal defect closure devices; and aspiration catheter neurovascular intervention product. Japan Lifeline Co., Ltd. was incorporated in 1981 and is headquartered in Tokyo, Japan.

Similar Companies

Industry: Medical Devices (Japan)
Name
Market Cap diff.
PE
7741
$61.41B
9.83T JPY
10K%
40.0
$22.07B
3.53T JPY
3K%
13.0
4543
$18.94B
3.03T JPY
3K%
23.7
7733
$10.76B
1.72T JPY
2K%
20.7
7701
$6.58B
1.05T JPY
969%
18.6
$5.47B
875.04B JPY
788%
50.1
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
$173.27B
28K%
25.8
$160.73B
26K%
56.7
$159.07B
26K%
25.6
DHR
$126.55B
20K%
34.7
SYK
$120.69B
20K%
38.3
MDT
$101.9B
16K%
22.2
chevron_leftBack